期刊文献+

伊曲康唑注射液治疗ICU侵袭性真菌感染的临床效果观察 被引量:8

下载PDF
导出
摘要 目的:探讨伊曲康唑注射液治疗ICU侵袭性真菌感染的临床疗效。方法:将40例ICU侵袭性真菌感染患者随机的分为对照组和试验组两组,对照组患者给予氟康唑治疗,试验组患者给予伊曲康唑注射液治疗,观察两组患者的治疗效果。结果:试验组患者所获得的总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论:伊曲康唑注射液治疗ICU侵袭性真菌感染可以获得比较好的疗效,值得在临床上推广应用。
作者 林峰 洪建湘
出处 《吉林医学》 CAS 2012年第18期3896-3896,共1页 Jilin Medical Journal
  • 相关文献

参考文献4

二级参考文献25

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2朱利平,杨飞飞,翁心华,黄玉仙,陈澍,施光峰,卢清,张文宏,张永信.伊曲康唑注射液治疗侵袭性真菌感染的肝脏安全性研究[J].中华医学杂志,2006,86(29):2028-2032. 被引量:8
  • 3VICENTE M F,BASLLIO A,CABELLO A,et al.Mic-robial natural product as a source of antifungals[J].Clin Microbi Infect,2003,9(1):15-32.
  • 4MARTIN G S,MANNINO D M,EATON S,et al.The epi-demiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-1554.
  • 5MARRK A,CARTER R A,BOECKH M,et al.Invasive aspergillosis in allogeneic stem-cell transplante recipients; changes in epidemiology and risk factors[J].Blood,2002,100(13):4358-4366.
  • 6PAPPAS P G,REX J H,SOBEL J D,et al.Guideline for treatment of candidiasis[J].Clin Infect Dis,2004,38(2):161-189.
  • 7GROLL A H,SHAH P,MENTZEL C,et al.Trends in the postmortem epidemiology of invasive fungal infections at a university hospital[J].J Infect,1996,33(1):23-32.
  • 8GEORGOPAPADAKOU N H.Update on antifungals targe-ted to the cell wall:focus on beta-1,3-glucan synthase inhibitors[J].Expert Opin Investig Drugs,2001,10(2):269-280.
  • 9PFALLER M,RILEY J,KOEMER T.Effect of cilofungin(LY121019) on carbohydrate and sterol composition of candida albicans[J].Eur J Clin Microbiol Infect Dis,1989,8(12):1067-1070.
  • 10ANGIOLELLA L,FACCHIN M,STRINGARO A,et al.Ide-ntification of a glucan-associated endase as a main cell wall protein of candida albicans and an indirect target of lipopeptide antimycotics[J].J Infect Dis,1996,173(3):684-690.

共引文献19

同被引文献67

  • 1张盛忠,刘红刚,刘铭,杜江,王毓新.鼻-鼻窦侵袭型真菌病的临床和病理学观察[J].中华耳鼻咽喉头颈外科杂志,2005,40(1):37-40. 被引量:37
  • 2黄少鹏,李瑞玉,叶青,王一红.鼻内镜手术治疗真菌球型鼻窦炎52例[J].福建医科大学学报,2007,41(4):377-378. 被引量:5
  • 3贝政平,舒怀,周梁.眼耳鼻咽喉科疾病诊断标准[M].北京:科学出版社,2001:295,296.
  • 4Ferguson BJ. Definitions of fungal rhinosinusitis[J]. Oto- laryngol Clin North Am,2000,33(2) :227-235.
  • 5Tumbarello M, Pesteraro B, Trecariehi EM, et al.Biofilm production by Candida species and inadequate antifungal therapy predictors ofmortality for patients with candidemia[J].JClin Micmbiol, 2007,45- 50.
  • 6R, Abizanda Campos,S, Altaba Tena,A,Belenguer Muncharaz,et al. Study of post-ICU mortality during 4 years (2006-2009). Analysis of the factors related to death in the ward after discharge from the ICU[J]. Medicina intensiva / Sociedad Espa?ola de Medicina Intensiva y Unidades Coronarias, 2011,35(3): 150-156.
  • 7Mulligan JK, Bleier BS, O' Connell B, et al. Vitamin D (3) corre- lates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhino- sinusitis J ]. Clin Exp Immunol,2011,164 (3) :312-320.
  • 8Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France,200 1-2010 [ J ]. Emerg Infect Dis, 2014,20(7) :1149-1155.
  • 9Yapar N. Epidemiology and risk factors for invasive candidiasis[ J]. Ther Clin Risk Manag,2014,10:95-105.
  • 10Chakrabarti A, Denning DW, Ferguson B J, et al. Fungal rhinosinus- itis: a categorization and definitional schema addressing current con- troversies [ J ]. Laryngoscope, 2009,119 ( 9 ) : 1809 -1818.

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部